Literature DB >> 20815854

Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: does it work outside the United States?

L McCormack1, A Gadano, J Lendoire, O Imventarza, O Andriani, O Gil, L Toselli, L Bisigniano, E de Santibañes.   

Abstract

BACKGROUND: In July 2005, Argentina was the first country after the United States to adopt the MELD system. The purpose of the present study was to analyse the impact of this new system on the adult liver waiting list (WL).
METHODS: Between 2005 and 2009, 1773 adult patients were listed for liver transplantation: 150 emergencies and 1623 electives. Elective patients were categorized using the MELD system. A prospective database was used to analyse mortality and probability to be transplanted (PTBT) on the WL.
RESULTS: The waiting time increased inversely with the MELD score and PTBT positively correlated with MELD score. With scores >/= 18 the PTBT remained over 50%. However, the largest MELD subgroup with <10 points (n = 433) had the lower PTBT (3%). In contrast, patients with T(2) hepatocellular carcinoma benefited excessively with the highest PTBT (84.2%) and the lowest mortality rate (5.4%). The WL mortality increased after MELD adoption (10% vs. 14.8% vs. P < 0.01). Patients with <10 MELD points had >fourfold probability of dying on the WL than PTBT (14.3% vs. 3%; P < 0.0001).
CONCLUSIONS: After MELD implementation, WL mortality increased and most patients who died had a low MELD score. A comprehensive revision of the MELD system must be performed to include cultural and socio-economical variables that could affect each country individually.

Entities:  

Mesh:

Year:  2010        PMID: 20815854      PMCID: PMC3030754          DOI: 10.1111/j.1477-2574.2010.00199.x

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  24 in total

1.  Partial left lateral segment transplant from a living donor.

Authors:  E de Santibañes; L McCormack; J Mattera; J Pekolj; J Sívori; A Beskow; D D'Agostino; M Ciardullo
Journal:  Liver Transpl       Date:  2000-01       Impact factor: 5.799

Review 2.  MELD and liver allocation: continuous quality improvement.

Authors:  Richard B Freeman
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

3.  Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine.

Authors:  F Villamil; G Levy; G L Grazi; S Mies; D Samuel; F Sanjuan; M Rossi; J Lake; S Munn; F Mühlbacher; L Leonardi; U Cillo
Journal:  Transplant Proc       Date:  2006-11       Impact factor: 1.066

4.  MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game.

Authors:  Didier Samuel
Journal:  J Hepatol       Date:  2009-01-09       Impact factor: 25.083

Review 5.  Patient selection in an era of donor liver shortage: current US policy.

Authors:  Russell H Wiesner
Journal:  Nat Clin Pract Gastroenterol Hepatol       Date:  2005-01

Review 6.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

7.  The survival benefit of liver transplantation.

Authors:  Robert M Merion; Douglas E Schaubel; Dawn M Dykstra; Richard B Freeman; Friedrich K Port; Robert A Wolfe
Journal:  Am J Transplant       Date:  2005-02       Impact factor: 8.086

8.  Should liver transplantation in patients with model for end-stage liver disease scores <or= 14 be avoided? A decision analysis approach.

Authors:  James D Perkins; Jeffrey B Halldorson; Ramasamy Bakthavatsalam; Oren K Fix; Robert L Carithers; Jorge D Reyes
Journal:  Liver Transpl       Date:  2009-02       Impact factor: 5.799

9.  Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory.

Authors:  J F Trotter; J Olson; J Lefkowitz; A D Smith; R Arjal; J Kenison
Journal:  Am J Transplant       Date:  2007-06       Impact factor: 8.086

10.  Liver transplantation: the last measure in the treatment of bile duct injuries.

Authors:  Eduardo de Santibañes; Victoria Ardiles; Adrian Gadano; Martin Palavecino; Juan Pekolj; Miguel Ciardullo
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

View more
  5 in total

1.  MELD-good for many, not as good for others … at least for now.

Authors:  Thomas Schiano
Journal:  Hepatol Int       Date:  2012-07-25       Impact factor: 6.047

Review 2.  Liver Diseases in Latin America: Current Status, Unmet Needs, and Opportunities for Improvement.

Authors:  Luis Antonio Díaz; Gustavo Ayares; Jorge Arnold; Francisco Idalsoaga; Oscar Corsi; Marco Arrese; Juan Pablo Arab
Journal:  Curr Treat Options Gastroenterol       Date:  2022-06-16

3.  Liver transplantation: fifty years of experience.

Authors:  Alice Tung Wan Song; Vivian Iida Avelino-Silva; Rafael Antonio Arruda Pecora; Vincenzo Pugliese; Luiz Augusto Carneiro D'Albuquerque; Edson Abdala
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

4.  Liver Transplantation without Perioperative Transfusions Single-Center Experience Showing Better Early Outcome and Shorter Hospital Stay.

Authors:  Nicolás Goldaracena; Patricio Méndez; Emilio Quiñonez; Gustavo Devetach; Lucio Koo; Carlos Jeanes; Margarita Anders; Federico Orozco; Pablo D Comignani; Ricardo C Mastai; Lucas McCormack
Journal:  J Transplant       Date:  2013-12-12

5.  Hepatocellular carcinoma in Latin America: Diagnosis and treatment challenges.

Authors:  Federico Piñero; Jaime Poniachik; Ezequiel Ridruejo; Marcelo Silva
Journal:  World J Gastroenterol       Date:  2018-10-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.